HLF — Herbalife Share Price
- $652.64m
- $2.50bn
- $4.99bn
- 94
- 99
- 81
- 100
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 2.89 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | -22.86% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 3.99 | ||
Price to Sales | 0.13 | ||
EV to EBITDA | 4.94 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 25.07% | ||
Return on Equity | n/a | ||
Operating Margin | 7.52% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 5,541.8 | 5,802.8 | 5,204.4 | 5,062.4 | 4,993.1 | 4,942.39 | 5,137.84 | 0.47% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +26.13 | +55.6 | -21.36 | -38.76 | +56.22 | -36.1 | +25.82 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Herbalife Ltd. is a global nutrition company. The Company sells weight management; targeted nutrition; energy, sports and fitness; and other nutrition products to and through a network of independent members (Members). Its products include meal replacements, protein shakes, teas, aloes, high-protein snacks, vitamins and supplements, and sports nutrition. The Company offers a range of meal replacement products, such as protein shakes, bars, and soups. Its snack portfolio includes a variety of sweet, savory and creamy options, such as high protein iced coffee, protein bars, snack shakes, soups, and baking mixes. Its Herbal Aloe Concentrate is a beverage formulated with aloe vera, which can be mixed with water, tea or protein shake. It has also developed a portfolio of dietary supplements, including solutions for heart health, digestive health, immunity and others. It sells products in approximately 95 markets across the world.
Directors
- John Agwunobi CHM (56)
- John DeSimone PRE (54)
- Alexander Amezquita CFO (47)
- Mark Schissel COO (53)
- Henry Wang EVP (51)
- Alan Hoffman EVP (54)
- Robert Levy EVP (62)
- Thomas Harms SVP (59)
- Edi Hienrich SVP (59)
- Joe Miranda OTH
- Alan LeFevre LED (61)
- Juan Mendoza DRC (47)
- John Tartol DRC (69)
- Richard Carmona IND (71)
- Kevin Jones IND (52)
- Sophie L'Helias IND (57)
- Donal Mulligan IND (60)
- Maria Otero IND (70)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 4th, 2002
- Public Since
- December 16th, 2004
- No. of Shareholders
- 474
- No. of Employees
- 8,600
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
New York Stock Exchange
- Shares in Issue
- 101,341,321

- Address
- Ugland House, South Church Street, GRAND CAYMAN, 00000
- Web
- https://www.herbalife.com/
- Phone
- +1 3453104109600
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for HLF
Herbalife Ltd Annual Shareholders Meeting
Q1 2025 Herbalife Ltd Earnings Release
Q1 2025 Herbalife Ltd Earnings Call
Q2 2025 Herbalife Ltd Earnings Release
Similar to HLF
Adecoagro SA
New York Stock Exchange
Altria
New York Stock Exchange
Archer-Daniels-Midland Co
New York Stock Exchange
B&G Foods
New York Stock Exchange
Bellring Brands
New York Stock Exchange
FAQ
As of Today at 21:04 UTC, shares in Herbalife are trading at $6.44. This share price information is delayed by 15 minutes.
Shares in Herbalife last closed at $6.44 and the price had moved by -21.75% over the past 365 days. In terms of relative price strength the Herbalife share price has underperformed the S&P500 Index by -26.42% over the past year.
The overall consensus recommendation for Herbalife is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreHerbalife does not currently pay a dividend.
Herbalife does not currently pay a dividend.
Herbalife does not currently pay a dividend.
To buy shares in Herbalife you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $6.44, shares in Herbalife had a market capitalisation of $652.64m.
Here are the trading details for Herbalife:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: HLF
Based on an overall assessment of its quality, value and momentum Herbalife is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Herbalife is $9.33. That is 44.88% above the last closing price of $6.44.
Analysts covering Herbalife currently have a consensus Earnings Per Share (EPS) forecast of $2.07 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Herbalife. Over the past six months, its share price has outperformed the S&P500 Index by +1.95%.
As of the last closing price of $6.44, shares in Herbalife were trading -18.34% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Herbalife PE ratio based on its reported earnings over the past 12 months is 2.89. The shares last closed at $6.44.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Herbalife's management team is headed by:
- John Agwunobi - CHM
- John DeSimone - PRE
- Alexander Amezquita - CFO
- Mark Schissel - COO
- Henry Wang - EVP
- Alan Hoffman - EVP
- Robert Levy - EVP
- Thomas Harms - SVP
- Edi Hienrich - SVP
- Joe Miranda - OTH
- Alan LeFevre - LED
- Juan Mendoza - DRC
- John Tartol - DRC
- Richard Carmona - IND
- Kevin Jones - IND
- Sophie L'Helias - IND
- Donal Mulligan - IND
- Maria Otero - IND